MetLife, Inc. (NYSE:MET – Get Free Report) has earned a consensus rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $107.12.
Several brokerages recently issued reports on MET. Evercore reiterated a “mixed” rating on shares of MetLife in a report on Monday, August 24th. TD Cowen boosted their price objective on MetLife from $110.00 to $114.00 and gave the stock a “buy” rating in a research note on Wednesday, October 21st. Jefferies Financial Group upped their target price on MetLife from $103.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. JPMorgan Chase & Co. increased their target price on MetLife from $108.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, October 15th. Finally, UBS Group raised their target price on MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, October 6th.
Check Out Our Latest Report on MetLife
MetLife Price Performance
Shares of MetLife stock opened at $102.67 on Monday. The business’s fifty day moving average price is $98.75 and its 200 day moving average price is $86.90. MetLife has a twelve month low of $67.33 and a twelve month high of $106.72. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $64.52 billion, a P/E ratio of 13.39, a PEG ratio of 0.97 and a beta of 0.79.
MetLife (NYSE:MET – Get Free Report) last issued its earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.77 by $0.01. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The business had revenue of $20.52 billion during the quarter, compared to analysts’ expectations of $19.86 billion. During the same quarter in the previous year, the business earned $2.34 EPS. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. As a group, research analysts anticipate that MetLife will post 9.91 earnings per share for the current year.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be given a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a yield of 2.3%. MetLife’s dividend payout ratio (DPR) is 30.90%.
MetLife announced that its board has initiated a share repurchase plan on Wednesday, August 5th that permits the company to buy back $3 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its stock is undervalued.
Top MetLife Stories
Investors following MET have been watching these stories:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
Insider Activity at MetLife
In other news, CEO Michel Khalaf sold 187,425 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the transaction, the chief executive officer directly owned 759,013 shares of the company’s stock, valued at approximately $78,155,568.61. The trade was a 19.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.40% of the company’s stock.
Institutional Trading of MetLife
Large investors have recently modified their holdings of the business. Mowery & Schoenfeld Wealth Management LLC purchased a new position in MetLife in the second quarter valued at about $26,000. Burk Holdings LLC acquired a new stake in MetLife during the 2nd quarter valued at approximately $27,000. Nvwm LLC increased its holdings in MetLife by 655.3% during the 3rd quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 249 shares during the last quarter. Highland Investment Advisors LLC purchased a new stake in MetLife during the 2nd quarter worth approximately $30,000. Finally, Meeder Asset Management Inc. raised its position in shares of MetLife by 156.5% in the 3rd quarter. Meeder Asset Management Inc. now owns 354 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 216 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
See Also
- Five stocks we like better than MetLife
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
